Cogentia Healthcare Consulting

Cogentia is a leading market access and HEOR consultancy, delivering integrated projects across the whole product lifecycle from early development through to HTA submissions and gaining access.

We cover cell and gene therapies, rare diseases and all major therapeutic areas, and we work across pharmaceutical, device and diagnostic sectors from start-ups to big pharma.

Our team brings a range of expertise and experience from industry, consulting, public health and academia. We can provide integrated solutions, combining economic and access elements within one project. Building on a deep market understanding, we deliver projects from opportunity assessments, access strategy and early economic modelling through to payer engagement, value messaging, health economic modelling, and HTA submissions. We work with many clients in refining and optimising their target product profiles and evidence development plans. Our extensive payer and KOL network support insight development and validation.

The Cogentia way of working is collaborative, flexible and pragmatic, we work as a close partner and part of the team, focused on your challenges and requirements.

 If you are looking for clear and robust thinking, an innovative and bespoke approach, detailed analysis and insight, we’d be delighted to discuss your needs.